Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Institut Pasteur Korea

Division of Institut Pasteur
www.ip-korea.org

Latest From Institut Pasteur Korea

Asia Deal Watch: Takeda, Eisai Team With Non-Profit On Review Of Novel Targets For Antibiotics

The Japanese pharmaceutical companies will work with the Global Antibiotic Research and Development Partnership on screening targets for utility against WHO-listed priority pathogens. Avacta and LG Chem collaborate around the former’s Affimer technology.

Asia Pacific Deals

Interview: Kainos Aims To Open New Era With Novel Parkinson’s Drug

Kainos Medicine’s senior vice president sat down with Scrip to talk about the progress and ambitions for its first-in-class, potentially disease modifying Parkinson's disease drug candidate. If the drug candidate successfully goes through a Phase IIa in the US, it is set to draw robust interest from multinational pharmas which are already active in the area that lacks fundamental treatments.

South Korea Research & Development

Korean Pharma Taking To Open Innovation In Diverse Ways

The South Korean biopharma sector is adopting new approaches to beef up original R&D including open innovation, with Hanmi and LegoChem both recently setting up new operations to pursue collaborations as they look to expand internationally.

Asia Pacific Asia Pacific

Deals Shaping The Medical Industry, December 2013

Derived from Strategic Transactions, Elsevier Business Intelligence’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced October through November 2013.

BioPharmaceutical Medical Device
See All
UsernamePublicRestriction

Register